Evoke Wealth, LLC Revance Therapeutics, Inc. Transaction History

Evoke Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$11.52 - $20.4 $3,456 - $6,120	300 New	300 $4,000
Q1 2022 May 10, 2022	SELL	$12.36 - $20.31 $1,421 - $2,335	-115 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$12.6 - $26.55 $1,449 - $3,053	115 New	115 $3,000
Q1 2020 May 07, 2020	SELL	$12.46 - $27.81 $5,307 - $11,847	-426 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$10.22 - $14.5 $4,353 - $6,177	426 New	426 $5.54 Million

233

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.